Reports for PFIZER CANADA ULC
Company Name
PFIZER CANADA ULC
Totals |
||
Shortage reports |
744 |
|
| Actual shortage: | 84 (11%) | |
| Anticipated shortage: | 7 (1%) | |
| Avoided shortage: | 48 (6%) | |
| Resolved: | 605 (81%) | |
Discontinuation Reports |
84 |
|
| To be discontinued: | 1 (1%) | |
| Discontinued: | 82 (98%) | |
| Reversed: | 1 (1%) | |
Late reports |
17 (2%) |
|
Overdue reports |
8 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| IDARUBICIN | 1MG | SOLUTION | Resolved | 2022-12-02 | 2023-02-11 | 176929 |
| IDARUBICIN | 1MG | SOLUTION | Resolved | 2023-08-16 | 2023-12-19 | 201980 |
| IDARUBICIN | 1MG | SOLUTION | Resolved | 2023-09-27 | 2024-01-13 | 205354 |
| IDARUBICIN | 1MG | SOLUTION | Actual shortage | 2024-02-15 | 2024-04-16 | 219730 |
| IDARUBICIN | 1MG | SOLUTION | Anticipated shortage | 2024-05-01 | 2024-05-01 | 226805 |
| IDARUBICIN | 1MG | SOLUTION | Anticipated shortage | 2024-05-01 | 2024-05-01 | 226809 |
| IMIPENEM AND CILASTATIN FOR INJECTION | 500MG 500MG | POWDER FOR SOLUTION | Resolved | 2017-03-14 | 2018-08-15 | 2148 |
| INDERAL-LA | 60MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2018-01-17 | 2018-02-08 | 36373 |
| INDERAL-LA | 80MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2018-01-17 | 2018-02-08 | 36376 |
| INDERAL-LA | 120MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2018-01-17 | 2018-02-08 | 36379 |
| INDERAL-LA | 160MG | CAPSULE (SUSTAINED-RELEASE) | Resolved | 2018-01-17 | 2018-02-08 | 36382 |
| INDERAL-LA | 60MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-17 | 2022-02-24 | 155247 |
| INDERAL-LA | 80MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-17 | 2022-02-24 | 155253 |
| INDERAL-LA | 120MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-24 | 2022-02-25 | 155568 |
| INDERAL-LA | 160MG | CAPSULE (EXTENDED RELEASE) CAPSULE (SUSTAINED-RELEASE) | Actual shortage | 2022-02-24 | 2022-02-25 | 155571 |
| IRINOTECAN | 20MG | SOLUTION | Resolved | 2017-03-13 | 2017-08-30 | 2042 |
| IRINOTECAN | 20MG | SOLUTION | Resolved | 2017-03-22 | 2017-06-22 | 3937 |
| IRINOTECAN | 20MG | SOLUTION | Resolved | 2017-12-20 | 2018-07-13 | 34022 |
| IRINOTECAN HYDROCHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2017-10-11 | 2018-01-19 | 25312 |
| IRINOTECAN HYDROCHLORIDE INJECTION USP | 20MG | SOLUTION | Avoided shortage | 2017-12-12 | 2018-02-26 | 32661 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VIZIMPRO | 30MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180953 |
| VIZIMPRO | 45MG | TABLET | Discontinued | 2023-01-13 | 2023-01-14 | 180956 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2021-04-16 | 2021-04-17 | 137600 |
| ZYVOXAM 600 MG | 600MG | TABLET | Discontinued | 2020-01-17 | 2022-01-17 | 103480 |